These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 25650244)

  • 21. Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme.
    England B; Huang T; Karsy M
    Tumour Biol; 2013 Aug; 34(4):2063-74. PubMed ID: 23737287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic alteration and clonal evolution of primary glioblastoma into secondary gliosarcoma.
    Li J; Zhao YH; Tian SF; Xu CS; Cai YX; Li K; Cheng YB; Wang ZF; Li ZQ
    CNS Neurosci Ther; 2021 Dec; 27(12):1483-1492. PubMed ID: 34605602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
    Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
    Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.
    Shen Y; Grisdale CJ; Islam SA; Bose P; Lever J; Zhao EY; Grinshtein N; Ma Y; Mungall AJ; Moore RA; Lun X; Senger DL; Robbins SM; Wang AY; MacIsaac JL; Kobor MS; Luchman HA; Weiss S; Chan JA; Blough MD; Kaplan DR; Cairncross JG; Marra MA; Jones SJM
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19098-19108. PubMed ID: 31471491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
    Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T
    Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolutionary Trajectories of IDH
    Körber V; Yang J; Barah P; Wu Y; Stichel D; Gu Z; Fletcher MNC; Jones D; Hentschel B; Lamszus K; Tonn JC; Schackert G; Sabel M; Felsberg J; Zacher A; Kaulich K; Hübschmann D; Herold-Mende C; von Deimling A; Weller M; Radlwimmer B; Schlesner M; Reifenberger G; Höfer T; Lichter P
    Cancer Cell; 2019 Apr; 35(4):692-704.e12. PubMed ID: 30905762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
    Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
    J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape.
    Mohme M; Maire CL; Schliffke S; Joosse SA; Alawi M; Matschke J; Schüller U; Dierlamm J; Martens T; Pantel K; Riethdorf S; Lamszus K; Westphal M
    Acta Neuropathol Commun; 2020 Mar; 8(1):28. PubMed ID: 32151286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological spectrum in recurrences of glioblastoma multiforme.
    Marucci G; Fabbri PV; Morandi L; De Biase D; Di Oto E; Tallini G; Sturiale C; Franceschi E; Frezza GP; Foschini MP
    Pathologica; 2015 Mar; 107(1):1-8. PubMed ID: 26591624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming therapeutic resistance in glioblastoma: the way forward.
    Osuka S; Van Meir EG
    J Clin Invest; 2017 Feb; 127(2):415-426. PubMed ID: 28145904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-generation whole exome sequencing of glioblastoma with a primitive neuronal component.
    Xu G; Zheng H; Li JY
    Brain Tumor Pathol; 2019 Jul; 36(3):129-134. PubMed ID: 30715630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
    Phi JH; Park AK; Lee S; Choi SA; Baek IP; Kim P; Kim EH; Park HC; Kim BC; Bhak J; Park SH; Lee JY; Wang KC; Kim DS; Shim KW; Kim SH; Kim CY; Kim SK
    Acta Neuropathol; 2018 Jun; 135(6):939-953. PubMed ID: 29644394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGAWES: variational segmentation on whole exome sequencing for copy number detection.
    Anjum S; Morganella S; D'Angelo F; Iavarone A; Ceccarelli M
    BMC Bioinformatics; 2015 Sep; 16():315. PubMed ID: 26416038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 37. Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.
    Riehmer V; Gietzelt J; Beyer U; Hentschel B; Westphal M; Schackert G; Sabel MC; Radlwimmer B; Pietsch T; Reifenberger G; Weller M; Weber RG; Loeffler M;
    Genes Chromosomes Cancer; 2014 Jul; 53(7):589-605. PubMed ID: 24706357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and epigenetic stability of oligodendrogliomas at recurrence.
    Aihara K; Mukasa A; Nagae G; Nomura M; Yamamoto S; Ueda H; Tatsuno K; Shibahara J; Takahashi M; Momose T; Tanaka S; Takayanagi S; Yanagisawa S; Nejo T; Takahashi S; Omata M; Otani R; Saito K; Narita Y; Nagane M; Nishikawa R; Ueki K; Aburatani H; Saito N
    Acta Neuropathol Commun; 2017 Mar; 5(1):18. PubMed ID: 28270234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
    Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
    J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.